The antitumor role of the miR-129-5p/HMGB1 axis was studied in osteosarcoma [45], hepatocellular carcinoma [48], breast cancer [43,44], gastric cancer [46,47], and colon cancer [45]. This evidence concerns the gene HMGB1 and breast cancer.